The US Food and Drug Administration (FDA) has approved an improved stool collection kit of Geneoscopy’s CRC screening test, ColoSense.

MeMed has developed MeMed BV Flex, a rapid infection differentiation test that distinguishes between bacterial and viral infections.

Edwards Lifesciences has lifted its 2025 profit outlook to between 9%-10%, up from 8%-10%, amid strong Q2 2025 performance in its Transcatheter Aortic Valve Replacement (TAVR) and Transcatheter Mitral ...

Following a period of relative dormancy, research and development in the Alzheimer’s disease space is booming. And mounting attention, both in the development of disease modifying therapies (DMTs) and ...

Charlie Whelan, a Senior Director of Consulting at GlobalData, discusses the latest trends in medical devices for 2025.

Roche’s Elecsys pTau181 test has secured CE Mark approval, marking a development in ruling out Alzheimer's disease.

The FDA has granted 510(k) clearance for Philips’ latest UroNav version, an advancement in image-guided navigation for prostate cancer care.

Nestmedic has chosen Curavit Clinical Research to spearhead the US clinical study of the remote prenatal monitoring solution, PregnaOne.

The Advanced Medical Technology Association (AdvaMed) has expressed support for the Trump administration’s artificial intelligence (AI) action plan.

The US Court of Appeals has overturned a $106.5m ruling wherein a California court jury found that Medtronic infringed on a heart valve replacement method developed by Colibri Heart Valve.

Healthcare investment company ARCHIMED’s affiliate is set to acquire ZimVie for an enterprise value of around $730m.

Medtronic’s MiniMed 780G system has received European CE Mark approval to expand the indications for use by people aged two years and above, during pregnancy, and for those with type 2 ...